Status:

UNKNOWN

The Use of Digital Genetic Assistant (DGA) for Expanded Carrier Screening

Lead Sponsor:

Igentify Ltd

Collaborating Sponsors:

Sheba Medical Center

Conditions:

Genetic Disease

Eligibility:

All Genders

18+ years

Brief Summary

The DGA provides an end-to-end digital solution to the preconception carrier screening process from participant registration to receipt of the test results and their interpretations. These steps are p...

Detailed Description

Participant Enrollment (pre-test): This system component enables the participant to start the process prior to the visit by enabling the participant to enter his/her personal information into the DGA...

Eligibility Criteria

Inclusion

  • Participants willing to undergo expanded preconception carrier screening (CarrierScan Screening Test).
  • Participants willing to use the DGA as part of their genetic screening.
  • Participants willing to fill up questionnaires about their experience and understanding of the genetic counseling and share their clinical and DGA usage data with the study personnel.
  • Fluent in Hebrew.
  • Couples (Male + Female) that plan to have children together.
  • Age above 18.

Exclusion

  • Individuals that undergo bone marrow transplantation.
  • Participants refusing to participate in the study.

Key Trial Info

Start Date :

April 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2022

Estimated Enrollment :

600 Patients enrolled

Trial Details

Trial ID

NCT04014114

Start Date

April 1 2020

End Date

April 1 2022

Last Update

January 29 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The Use of Digital Genetic Assistant (DGA) for Expanded Carrier Screening | DecenTrialz